NewsRoom Articles - Page 51 of 154 - PsychedelicNewsWire (PNW)

WednesdayAug 24, 2022 11:59 am

How Meditation, Psychedelics Can Boost Healing

Psychedelics have seen a surge in popularity amid significantly increased interest in both the mainstream and scientific communities. Initial studies show that these mind-altering drugs have the potential to alleviate mental health conditions such as post-traumatic disorder, anxiety, eating disorders and treatment-resistant depression. The studies revealed that even a single psychedelic trip can have profound long-term effects on a patient’s mental health. As such, researchers across the country have been working to develop psychedelic-assisted therapies that can have positive long-term mental health outcomes. Practitioners in the health and wellness sector have been particularly interested in psychedelics because of their ability…

TuesdayAug 23, 2022 11:56 am

California Senator Sees New Path to Get Psychedelics Decriminalization Bill Approved

The possession and use of psychedelic drugs won’t be allowed anytime soon in the state of California after a psychedelics bill failed to pass. Bill SB 519, which had advanced past the Senate, was passed by two committees and went through a series of amendments in an appropriations committee that removed ketamine from the list of allowed psychedelics and introduced possession limits. Despite that, psychedelic reform advocates say that the legislation was essentially gutted in an Assembly Appropriations Committee meeting last week, with lawmakers introducing provisions such as possession limits that irked many advocates. Before last week’s Appropriations Committee meeting,…

MondayAug 22, 2022 12:41 pm

FT-104: Field Trip’s Latest Psychedelic Drug Candidate

Thanks to increased scientific interest in psychedelics because of their purported mental health benefits, the substances have seen a significant resurgence in mainstream popularity. Reform activists across the country have spent the last couple of years trying to legalize psychedelics amid a slew of studies that have found the drugs to be quite effective at treating conditions such as depression, post-traumatic stress disorder (PTSD) and even eating disorders. This hasn’t been limited to popular psychedelics such as MDMA, ketamine and psilocybin, the main psychoactive agent in magic mushrooms. Activists were recently able to get the Drug Enforcement Administration (DEA) to…

FridayAug 19, 2022 12:24 pm

Women May Benefit Greatly from Psychedelics Renaissance

Over the past few years, there has been significantly increased interest in psychedelics among the scientific and mainstream community. Initial studies have found that they can alleviate mental health issues such as anxiety, depression and PTSD, and the media has been full of stories of people who benefited from psychedelic-assisted therapies. Research shows that veterans and terminal patients stand to benefit a great deal from psychedelic therapies because those treatments have been found to be effective at mitigating conditions that affect these two groups. However, what a lot of people may not know is that women could also benefit greatly…

ThursdayAug 18, 2022 4:04 pm

Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity

Psychedelic research has seen a significant surge in the past few years amid increased interest in psychedelics among the scientific community and the general public. Companies such as Mind Medicine (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) are developing psychedelic-inspired medicines and therapies to address addiction and mental health disorders. Studies have found that psychedelics have potential as alternative treatments for mental health conditions such as major depressive disorder and post-traumatic stress disorder (“PTSD”). Researchers have stepped up their efforts to study the potential benefits of psychedelics. New research has uncovered a possible link between lysergic acid diethylamide, or "LSD” and…

WednesdayAug 17, 2022 1:35 pm

Psychedelics Advocates Put DEA Under Pressure Over Right to Try Laws

As per the federal and state Right-to-Try laws, terminally ill patients in the United States are allowed access to experimental drugs that have advanced past phase I testing but still haven’t received approval from the U.S. Food and Drug Administration. In 2018, 41 states had passed right-to-try laws on top of the federal Right to Try Act, meaning a majority of Americans could access unapproved drugs should they need them. With psychedelics currently experiencing a surge in mainstream and scientific interest due to their potential as alternative mental health treatments, there has been increased interest in the mind-altering drugs for…

WednesdayAug 17, 2022 9:30 am

Silo Pharma Inc. (SILO): Promising Psylocibin Study Ongoing with UCSF

Company entered scientific research agreement with UCSF in June 2021 to study psilocybin effects on various inflammatory conditions Silo Pharma (OTCQB: SILO), recently announced that the University of California San Francisco (“UCSF”) had successfully administered psilocybin to a test group of Parkinson’s disease patients as part of a scientific research agreement (“SRA”) entered with Silo in June, 2021 to “to determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, Bipolar disorder, and chronic back pain. “Successful dosing and collection of blood samples from enrolled patients is an important milestone that demonstrates the progress being made…

TuesdayAug 16, 2022 2:48 pm

Important Clinical Trials That May Result in Psychedelic Legalization

Initial studies have found that certain psychedelics have plenty of potential as treatments for mental health conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder. Furthermore, activists across the country have put forth a variety of measures to decriminalize psychedelics, with cities such as Denver moving to decriminalize all psychedelics. But before psychedelics can be approved for widespread medical use, they will have to go through the clinical trial system successfully. This process involves three phases: phase I trials where animals are used to test the efficacy and safety of drugs; phase 2 trials involving several dozen patients…

MondayAug 15, 2022 1:16 pm

Second Psychedelics Initiative Fails to Qualify for Colorado Ballot

Psychedelic enthusiasts, activists and researchers in Colorado will be sad to know that there won’t be two measures to legalize psychedelics on the November ballot. Two separate campaigns have pushed their own psychedelic measures since the start of the year, with only one campaign managing to collect enough signatures to qualify for the ballot. In late July, activists behind the Natural Medicine Health Act submitted around 100,000 signatures to the secretary of state’s office. The measure wants to legalize the possession of specific psychedelics, seal the records of people with prior psychedelic convictions and create a framework for psilocybin treatments.…

FridayAug 12, 2022 2:06 pm

Psilocybin Lawsuit Filed in Canada May Boost Global Psychedelics Reform Efforts

Canada banned psychedelics more than 30 years ago, outlawing the production, sale and use of psychedelics, including psilocybin, for decades. Most countries around the world followed suit and banned psychedelics. However, psychedelic drugs were still quite popular despite being prohibited due to their mind-altering effects. In recent years, this mainstream popularity has reached an explosive level, especially regarding psychedelics' ability to treat mental health conditions, resulting in a surge in psychedelic research. A new psilocybin lawsuit in Canada now has the potential to spur a wave of psychedelics reform not only in Canada but in the United States as well.…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000